Show Notes
October 28, 2026 - A brilliant founder. An impressive board. A compelling story. None of those proves the investment works. Zach Abraham and Chase Taylor revisit Elizabeth Holmes and Theranos to examine how confidence and famous names can lend credibility to claims investors should be questioning.
A discussion of a Holmes documentary opens a broader conversation about trust, due diligence and why some investors remain willing to back people associated with spectacular failures. What happens when the reputation surrounding a business becomes more persuasive than the evidence behind it? Elsewhere, Zach and Chase explore a different investing tension: slowing AI spending could improve cash flow for the companies doing the building, even as suppliers benefit from spending more. They examine Oracle’s outlook, debate AI earnings expectations, and react as Microsoft and Alphabet move in opposite directions following their earnings releases.
Plus, rising oil prices, the Fed’s decision to hold rates steady, and the gap between political messaging on affordability and the costs households face.
Schedule your free Know Your Risk Review at KnowYourRiskRadio.com
More from Know Your Risk Podcast
October 27, 2026 - What if the biggest threat to today’s AI winners isn’t fading demand—but technology getting better? Zach Abraham and Chase Taylor examine how cheaper chips, more efficient systems and AI’s own breakthroughs could put pressure on the profit margins powering the stock-market boom.
October 26, 2026 - A political shock sends investors scrambling out of Brazil. Zach Abraham and Chase Taylor see a reason to start buying. Chase describes adding a small position in a Brazilian small-cap ETF that fell as much as 38% intraday before closing down roughly 31.6%—and explains why he thinks the selling went further than the underlying businesses justified.
October 23, 2026 - AI stocks have already delivered enormous gains. That doesn’t mean the best evidence points to a top. Zach Abraham and Chase Taylor explain their reluctant bullish case: demand could have much further to run, and some of the companies supplying the buildout look surprisingly inexpensive if projected earnings materialize.
October 22, 2026 - The AI buildout can keep going while shareholders pay a growing price. Zach Abraham and Chase Taylor examine Meta’s financing plans and the risk that issuing more stock to fund enormous spending commitments dilutes the investors already holding shares . The tension runs through a confusing market session: AI stocks and gold miners fall, Apple rallies, oil climbs and bond yields drop. Is this an economic warning, investors unwinding crowded trades, or a combination of both? Zach and Chase explain why they’re questioning the signals without declaring the AI investment cycle over.
October 21, 2026 - A Tesla–SpaceX combination could give investors a bigger growth story. But who would actually be funding it? Zach Abraham and Chase Taylor unpack the merger talk and question whether Tesla shareholders would be financing SpaceX’s capital demands while still paying a growth-stock valuation.